Epigenetic targets of some toxicologically relevant metals: A review of the literature

Journal of Applied Toxicology

Volumn 32, Issue 9, 2012, Pages 643-653

  Cheng, Tsu Fan ^a   Choudhuri, Supratim ^a   Muldoon Jacobs, Kristi ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

DNA methylation; Epigenetics; Gene expression; Histone modification; Inorganic heavy metals; Noncoding RNA; Organic metals

Indexed keywords

ARSENIC; CADMIUM; CHROMIUM; COPPER; HEAVY METAL; LEAD; METHYLMERCURY; NICKEL; ORGANOTIN COMPOUND;

CARCINOGENICITY; CELL PROLIFERATION; CELL TRANSFORMATION; DNA METHYLATION; DNA STRAND BREAKAGE; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC TOXICOLOGY; HISTONE MODIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; UBIQUITINATION;

ANIMALS; DNA METHYLATION; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE EXPRESSION; HISTONES; HUMANS; METALS, HEAVY; ORGANOMETALLIC COMPOUNDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, UNTRANSLATED;

EID: 84864000264     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2717     Document Type: Review

References (105)

1. Ali AH, Kondo K, Namura T, Senba Y, Takizawa H, Nakagawa Y, Toba H, Kenzaki K, Sakiyama S, Tangoku A. 2011. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol. Carcinog. 50: 89-99.
2. Arita A, Costa M. 2009. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 1: 222-228.
3. Baccarelli A, Bollati V. 2009. Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 21: 243-251.
4. Bal W, Protas AM, Kasprzak KS. 2011. Genotoxicity of metal ions: chemical insights. Met. Ions Life Sci. 8: 319-373.
5. Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW, Lahiri DK, Zawia NH. 2005. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25: 823-829.
6. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP. 2007. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ. Health Perspect. 115: 1454-1459.
7. Bihaqi SW, Huang H, Wu J, Zawia NH. 2011. Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's Disease. J. Alzheimers Dis. Sep 2 27: 819-833.
8. Boellmann F, Zhang L, Clewell HJ, Schroth GP, Kenyon EM, Andersen ME, Thomas RS. 2010. Genome-wide analysis of DNA methylation and gene expression changes in the mouse lung following subchronic arsenate exposure. Toxicol. Sci. 117: 404-417.
9. Boyer IJ. 1989. Toxicity of dibutyltin, tribuityltin and other organotin compounds to humans and to experimental animals. Toxicology 55: 253-298.
10. Chen H, Liu J, Merrick BA, Waalkes MP. 2001. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol. Carcinog. 30: 79-87.
11. Chen H, Ke Q, Kluz T, Yan Y, Costa M. 2006. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol. Cell. Biol. 26: 3728-3737.
12. Chen H, Giri NC, Zhang R, Yamane K, Zhang Y, Maroney M, Costa M. 2010a. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J. Biol. Chem. 285: 7374-7383.
13. Chen H, Kluz T, Zhang R, Costa M. 2010b. Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis 31: 2136-2144.
14. Cheng RY, Hockman T, Crawford E, Anderson LM, Shiao YH. 2004. Epigenetic and gene expression changes related to transgenerational carcinogenesis. Mol. Carcinog. 40: 1-11.
15. Choudhuri S. 2010. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology. J. Biochem. Mol. Toxicol. 24: 195-216.
16. Choudhuri S. 2011. From Waddington's epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research. Toxicol. Mech. Methods 21: 252-274.
17. Choudhuri S, Cui Y, Klaassen CD. 2010. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 245: 378-393.
18. Chu F, Ren X, Chasse A, Hickman T, Zhang L, Yuh J, Smith MT, Burlingame AL. 2011. Quantitative mass spectrometry reveals the epigenome as a target of arsenic. Chem. Biol. Interact. 192: 113-117.
19. Coneyworth LJ, Mathers JC, Ford D. 2009. Does promoter methylation of the SLC30A5 (ZnT5) zinc transporter gene contribute to the ageing-related decline in zinc status? Proc. Nutr. Soc. 68: 142-147.
20. Costa M, Davidson TL, Chen H, Ke Q, Zhang P, Yan Y, Huang C, Kluz T. 2005. Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat. Res. 592: 79-88.
21. De Oliveira JV, Boufleur LA, Dos Santos CE, Dias JF, Squeff CH, Silva GR, Ianistcki M, Benvegnú VC, Da Silva J. 2011. Occupational genotoxicity among copper smelters. Toxicol. Ind. Health Oct 31 [epub ahead of print].
22. Desaulniers D, Xiao GH, Lian H, Feng YL, Zhu J, Nakai J, Bowers WJ. 2009. Effects of mixtures of polychlorinated biphenyls, methylmercury, and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley rats. Int. J. Toxicol. 28: 294-307.
23. Doi T, Puri P, McCann A, Bannigan J, Thompson J. 2011. Epigenetic effect of cadmium on global de novo DNA hypomethylation in the cadmium-induced ventral body wall defect (VBWD) in the chick model. Toxicol. Sci. 120: 475-480.
24. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, Haefliger C, Horton R, Howe K, Jackson DK, Kunde J, Koenig C, Liddle J, Niblett D, Otto T, Pettett R, Seemann S, Thompson C, West T, Rogers J, Olek A, Berlin K, Beck S. 2006. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38: 1378-1385.
25. Ellen TP, Kluz T, Harder ME, Xiong J, Costa M. 2009. Heterochromatinization as a potential mechanism of nickel-induced carcinogenesis. Biochemistry 48: 4626-4632.
26. Esteller M, Herman JG. 2002. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196: 1-7.
27. Fujishiro H, Okugaki S, Yasumitsu S, Enomoto S, Himeno S. 2009. Involvement of DNA hypermethylation in down-regulation of the zinc transporter ZIP8 in cadmium-resistant metallothionein-null cells. Toxicol. Appl. Pharmacol. 241: 195-201.
28. Gardner KE, Allis CD, Strahl BD. 2011. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409: 36-46.
29. Globisch D, Munzel M, Muller M, Michalakis S, Wagner M, Koch S, Bruckl T, Biel M, Carell T. 2010. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 5: e15367.
30. Govindarajan B, Klafter R, Miller MS, Mansur C, Mizesko M, Bai X, LaMontagne K, Jr., Arbiser JL. 2002. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol. Med. 8: 1-8.
31. Grotto D, Barcelos GR, Valentini J, Antunes LM, Angeli JP, Garcia SC, Barbosa F Jr. 2009. Low levels of methylmercury induce DNA damage in rats: protective effects of selenium. Arch. Toxicol. 83: 249-254.
32. Grun F. 2010. Obesogens. Curr. Opin. Endocrinol. Diabetes Obes. 17: 453-459.
33. Guha Mazumder D, Dasgupta UB. 2011. Chronic arsenic toxicity: studies in West Bengal, India. Kaohsiung J. Med. Sci. 27: 360-370.
34. Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, Toubaji A, Argani P, Iacobuzio-Donahue C, Nelson WG, Netto GJ, De Marzo AM, Yegnasubramanian S. 2011. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2: 627-637.
35. Hagger JA, Fisher A, Hill SJ, Depledge MH, Jha AN. 2002. Genotoxic, cytotoxic and ontogenetic effects of tri-n-butyltin on the marine worm, Platynereis dumerilii (Polychaeta: Nereidae). Aquat. Toxicol. 57: 243-255.
36. Hamburger V, Hamilton HL. 1992. A series of normal stages in the development of the chick embryo. 1951. Dev. Dyn. 195: 231-272.
37. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. 2011. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303-1307.
38. Horiguchi T, Shiraishi H, Shimizu M, Morita M. 1997. Effects of triphenyltin chloride and five other organotin compounds on the development of imposex in the rock shell, Thais clavigera. Environ. Pollut. 95: 85-91.
39. Huang D, Zhang Y, Qi Y, Chen C, Ji W. 2008. Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol. Lett. 179: 43-47.
40. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. 2010. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5: e8888.
41. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. 2011. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303.
42. Ji W, Yang L, Yu L, Yuan J, Hu D, Zhang W, Yang J, Pang Y, Li W, Lu J, Fu J, Chen J, Lin Z, Chen W, Zhuang Z. 2008. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 29: 1267-1275.
43. Jiang G, Xu L, Song S, Zhu C, Wu Q, Zhang L, Wu L. 2008. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 244: 49-55.
44. 2+-induced human hepatoma cell apoptosis. J. Biol. Inorg. Chem. 10: 190-198.
45. Kang J, Zhang Y, Chen J, Chen H, Lin C, Wang Q, Ou Y. 2003. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. Toxicol. Sci. 74: 279-286.
46. Kang J, Lin C, Chen J, Liu Q. 2004. Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity. Chem. Biol. Interact. 148: 115-123.
47. Karaczyn AA, Bal W, North SL, Bare RM, Hoang VM, Fisher RJ, Kasprzak KS. 2003. The octapeptidic end of the C-terminal tail of histone H2A is cleaved off in cells exposed to carcinogenic nickel(II). Chem. Res. Toxicol. 16: 1555-1559.
48. Karaczyn AA, Golebiowski F, Kasprzak KS. 2005. Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II). Chem. Res. Toxicol. 18: 1934-1942.
49. Kasuba V, Rozgaj R, Milic M, Zeljezic D, Kopjar N, Pizent A, Kljakovic-Gaspic Z. 2010. Evaluation of lead exposure in battery-manufacturing workers with focus on different biomarkers. J. Appl. Toxicol. 30: 321-328.
50. Ke Q, Davidson T, Chen H, Kluz T, Costa M. 2006. Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 27: 1481-1488.
51. Ke Q, Ellen TP, Costa M. 2008a. Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity. Toxicol. Appl. Pharmacol. 228: 190-199.
52. Ke Q, Li Q, Ellen TP, Sun H, Costa M. 2008b. Nickel compounds induce phosphorylation of histone H3 at serine 10 by activating JNK-MAPK pathway. Carcinogenesis 29: 1276-1281.
53. Kondo K, Takahashi Y, Hirose Y, Nagao T, Tsuyuguchi M, Hashimoto M, Ochiai A, Monden Y, Tangoku A. 2006. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. Lung Cancer 53: 295-302.
54. Koturbash I, Beland FA, Pogribny IP. 2011. Role of epigenetic events in chemical carcinogenesis - a justification for incorporating epigenetic evaluations in cancer risk assessment. Toxicol. Mech. Method. 21: 289-297.
55. Kowara R, Salnikow K, Diwan BA, Bare RM, Waalkes MP, Kasprzak KS. 2004. Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas. Mol. Cell. Biochem. 255: 195-202.
56. Kriaucionis S, Heintz N. 2009. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
57. Ku CS, Naidoo N, Wu M, Soong R. 2011. Studying the epigenome using next generation sequencing. J. Med. Genet. 48: 721-730.
58. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, Lutterbaugh J, Rerko RM, Casey G, Issa JP, Willis J, Willson JK, Plass C, Markowitz SD. 2003a. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl Acad. Sci. USA 100: 8412-8417.
59. Li J, Gorospe M, Barnes J, Liu Y. 2003b. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J. Biol. Chem. 278: 13183-13191.
60. Maiti A, Drohat AC. 2011. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286: 35334-35338.
61. Marsit CJ, Eddy K, Kelsey KT. 2006. MicroRNA responses to cellular stress. Cancer Res. 66: 10843-10848.
62. Mass MJ, Wang L. 1997. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386: 263-277.
63. Melino S, Nepravishta R, Bellomaria A, Di MS, Paci M. 2009. Nucleic acid binding of the RTN1-CC-terminal region: toward the functional role of a reticulon protein. Biochemistry 48: 242-253.
64. Munzel M, Globisch D, Carell T. 2011. 5-Hydroxymethylcytosine, the sixth base of the genome. Angew. Chem. Int. Ed Engl. 50: 6460-6468.
65. Mylonas M, Plakatouras JC, Hadjiliadis N, Krezel A, Bal W. 2002. Potentiometric and spectroscopic studies of the interaction of Cu(II) ions with the hexapeptides AcThrAlaSerHisHisLysNH2, AcThrGluAlaHisHisLysNH2, AcThrGluSerAlaHisLysNH2 and AcThrGluSerHisAlaLysNH2, models of C-terminal tail of histone H2A. Inorg. Chim. Acta 339: 60-70.
66. Mylonas M, Krezel A, Plakatouras JC, Hadjiliadis N, Bal W. 2005. Interactions of transition metal ions with His-containing peptide models of histone H2A. J. Mol. Liquids 118: 119-129.
67. Nakanishi T, Kohroki J, Suzuki S, Ishizaki J, Hiromori Y, Takasuga S, Itoh N, Watanabe Y, Utoguchi N, Tanaka K. 2002. Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells. J. Clin. Endocrinol. Metab. 87: 2830-2837.
68. Nepravishta R, Bellomaria A, Polizio F, Paci M, Melino S. 2010. Reticulon RTN1-C(CT) peptide: a potential nuclease and inhibitor of histone deacetylase enzymes. Biochemistry 49: 252-258.
69. Nestor C, Ruzov A, Meehan R, Dunican D. 2010. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48: 317-319.
70. Nickens KP, Patierno SR, Ceryak S. 2010. Chromium genotoxicity: a double-edged sword. Chem. Biol. Interact. 188: 276-288.
71. Nunes AM, Zavitsanos K, Malandrinos G, Hadjiliadis N. 2010. Coordination of Cu(2+)and Ni(2+) with the histone model peptide of H2B N-terminal tail (1-31 residues): a spectroscopic study. Dalton Trans. 39: 4369-4381.
72. Onishchenko N, Karpova N, Sabri F, Castren E, Ceccatelli S. 2008. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J. Neurochem. 106: 1378-1387.
73. Osada S, Nishikawa J, Nakanishi T, Tanaka K, Nishihara T. 2005. Some organotin compounds enhance histone acetyltransferase activity. Toxicol. Lett. 155: 329-335.
74. Ramirez T, Brocher J, Stopper H, Hock R. 2008. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. Chromosoma 117: 147-157.
75. Reichard JF, Schnekenburger M, Puga A. 2007. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 352: 188-192.
76. Riggs AD, Martienssen RA, Russo VEA. 1996. Introduction. In Epigenetic Mechanisms of Gene Regulation. CSHL Press: Cold Spring Harbor, NY; 1-4.
77. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coet-zee GA, Jones PA. 2006. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
78. Salnikow K, Zhitkovich A. 2008. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 21: 28-44.
79. Santos MM, Reis-Henriques MA, Vieira MN, Sole M. 2006. Triphenyltin and tributyltin, single and in combination, promote imposex in the gastropod Bolinus brandaris. Ecotoxicol. Environ. Saf. 64: 155-162.
80. Schnekenburger M, Talaska G, Puga A. 2007. Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol. Cell. Biol. 27: 7089-7101.
81. Sengupta SR, Das NK, Datta PK. 2008. Pathogenesis, clinical features and pathology of chronic arsenicosis. Indian J. Dermatol. Venereol. Leprol. 74: 559-570.
82. Smeester L, Rager JE, Bailey KA, Guan X, Smith N, Garcia-Vargas G, Del Razo LM, Drobna Z, Kelkar H, Stiyblo M, Fry RC. 2011. Epigenetic changes in individuals with arsenicosis. Chem. Res. Toxicol. 24: 165-167.
83. Somji S, Garrett SH, Toni C, Zhou XD, Zheng Y, Ajjimaporn A, Sens MA, Sens DA. 2011. Differences in the epigenetic regulation of MT-3 gene expression between parental and Cd+2 or As+3 transformed human urothelial cells. Cancer Cell Int. 11: 2.
84. Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, Li Y, Chen CH, Zhang W, Jian X, Wang J, Zhang L, Looney TJ, Zhang B, Godley LA, Hicks LM, Lahn BT, Jin P, He C. 2011. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29: 68-72.
85. Song MO, Li J, Freedman JH. 2009. Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol. Genom. 38: 386-401.
86. Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403: 41-45.
87. Strand J, Glahder CM, Asmund G. 2006. Imposex occurrence in marine whelks at a military facility in the high Arctic. Environ. Pollut. 142: 98-102.
88. Sutherland JE, Costa M. 2003. Epigenetics and the environment. Ann. NY Acad. Sci. 983: 151-160.
89. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
90. Takahashi Y, Kondo K, Hirose T, Nakagawa H, Tsuyuguchi M, Hashimoto M, Sano T, Ochiai A, Monden Y. 2005. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol. Carcinog. 42: 150-158.
91. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. 2003. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 286: 355-365.
92. Tomatis L. 1994. Transgeneration carcinogenesis: a review of the experimental and epidemiological evidence. Jpn. J. Cancer Res. 85: 443-454.
93. Vaissiere T, Sawan C, Herceg Z. 2008. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659: 40-48.
94. Wang H, Guan S, Quimby A, Cohen-Karni D, Pradhan S, Wilson G, Roberts RJ, Zhu Z, Zheng Y. 2011. Comparative characterization of the PvuRts1I family of restriction enzymes and their application in mapping genomic 5-hydroxymethylcytosine. Nucl. Acids Res. Aug 3 39: 9294-9305.
95. Wang Y, Wang C, Zhang J, Chen Y, Zuo Z. 2009. DNA hypomethylation induced by tributyltin, triphenyltin, and a mixture of these in Sebastiscus marmoratus liver. Aquat. Toxicol. 95: 93-98.
96. Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK, Zawia NH. 2008. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28: 3-9.
97. Xie FL, Huang SQ, Guo K, Xiang AL, Zhu YY, Nie L, Yang ZM. 2007a. Computational identification of novel microRNAs and targets in Brassica napus. FEBS Lett. 581: 1464-1474.
98. Xie Y, Liu J, Benbrahim-Tallaa L, Ward JM, Logsdon D, Diwan BA, Waalkes MP. 2007b. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 236: 7-15.
99. Zavitsanos K, Nunes AM, Malandrinos G, Hadjiliadis N. 2011. Copper effective binding with 32-62 and 94-125 peptide fragments of histone H2B. J. Inorg. Biochem. 105: 102-110.
100. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl Acad. Sci. USA 94: 10907-10912.
101. Zhong CX, Mass MJ. 2001. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol. Lett. 122: 223-234.
102. Zhou X, Sun H, Ellen TP, Chen H, Costa M. 2008a. Arsenite alters global histone H3 methylation. Carcinogenesis 29: 1831-1836.
103. Zhou ZS, Huang SQ, Yang ZM. 2008b. Bioinformatic identification and expression analysis of new microRNAs from Medicago truncatula. Biochem. Biophys. Res. Commun. 374: 538-542.
104. Zhou ZS, Zeng HQ, Liu ZP, Yang ZM. 2012. Genome-wide identification of Medicago truncatula microRNAs and their targets reveals their differential regulation by heavy metal. Plant Cell Environ. Sep 5 35: 86-99.
105. Zoroddu MA, Kowalik-Jankowska T, Kozlowski H, Molinari H, Salnikow K, Broday L, Costa M. 2000. Interaction of Ni(II) and Cu(II) with a metal binding sequence of histone H4: AKRHRK, a model of the H4 tail. Biochim. Biophys. Acta 1475: 163-168.